Your browser doesn't support javascript.
loading
Current recommendations on the role of diet in the aetiology and management of IBD.
Gerasimidis, Konstantinos; Godny, Lihi; Sigall-Boneh, Rotem; Svolos, Vaios; Wall, Catherine; Halmos, Emma.
Afiliación
  • Gerasimidis K; Human Nutrition, School of Medicine, University of Glasgow, Glasgow, UK.
  • Godny L; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
  • Sigall-Boneh R; Paediatric Gastroenterology and Nutrition Unit, Wolfson Medical Center, Holon and the Sackler Faculty of Medicine, Tel Aviv University, Israel, Holon, Israel.
  • Svolos V; Human Nutrition, School of Medicine, University of Glasgow, Glasgow, UK.
  • Wall C; Department of Medicine and Department of Human Nutrition, University of Otago Dunedin School of Medicine, Christchurch, New Zealand.
  • Halmos E; Department of Gastroenterology, Central Clinical School, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia.
Frontline Gastroenterol ; 13(2): 160-167, 2022.
Article en En | MEDLINE | ID: mdl-35300465
ABSTRACT
Diet is a key modifier of risk of inflammatory bowel disease development and potentially a treatment option in patients with established disease. International organisations in gastroenterology and inflammatory bowel disease have published guidelines for the role of diet in disease onset and its management. Here, we discuss the major overarching themes arising from these guidelines and appraise recent literature on the role of diet for inflammatory bowel disease prevention, treatment of active disease and maintenance of remission, considering these themes. Except for exclusive enteral nutrition in active Crohn's disease, we currently possess very little evidence to make any further dietary recommendations for the management of inflammatory bowel disease. There is also currently uncertainty on the extrapolation of epidemiological dietary signals on risk of disease development and preclinical experiments in animal models to management, once disease is established. Until high-quality evidence from clinical research becomes available, the only specific recommendations for inflammatory bowel disease we might safely give are those of healthy eating which apply for the general population for overall health and well-being.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Frontline Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Frontline Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido